Syros Pharmaceuticals (SYRS) Q4 2023 Earnings

Mar 27Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.18
-1.74
-1.29
-0.85

Details

Expected EPS
-1.14
Actual EPS
-2.18
Surprise EPS
-1.04
Surprise Percent
-91.23%

Description

⁨Syros Pharmaceuticals⁩ (⁦SYRS⁩) has reported earnings of ⁦-2.18⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts